Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PERINDOPRIL ERBUMINE Cause C-reactive protein increased? 11 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of C-reactive protein increased have been filed in association with PERINDOPRIL ERBUMINE (Perindopril Erbumine). This represents 0.9% of all adverse event reports for PERINDOPRIL ERBUMINE.

11
Reports of C-reactive protein increased with PERINDOPRIL ERBUMINE
0.9%
of all PERINDOPRIL ERBUMINE reports
0
Deaths
10
Hospitalizations

How Dangerous Is C-reactive protein increased From PERINDOPRIL ERBUMINE?

Of the 11 reports, 10 (90.9%) required hospitalization.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PERINDOPRIL ERBUMINE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does PERINDOPRIL ERBUMINE Cause?

Acute kidney injury (140) Dyspnoea (110) Drug ineffective (96) Hypertension (94) Angioedema (92) Hypotension (83) Headache (79) Fall (69) Off label use (69) Asthma (62)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which PERINDOPRIL ERBUMINE Alternatives Have Lower C-reactive protein increased Risk?

PERINDOPRIL ERBUMINE vs PERJETA PERINDOPRIL ERBUMINE vs PERMETHRIN PERINDOPRIL ERBUMINE vs PEROSPIRONE PERINDOPRIL ERBUMINE vs PERPHENAZINE PERINDOPRIL ERBUMINE vs PERTUZUMAB

Related Pages

PERINDOPRIL ERBUMINE Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased PERINDOPRIL ERBUMINE Demographics